Colinz Laboratories Intrinsic Value
Colinz Laboratories (COLINZ) median intrinsic value is ₹39.12 from 8 valuation models (range ₹30–₹67), vs current price ₹42.01 — -6.9% downside (Trading Near Calculated Value), margin of safety -7.4%. Browse Colinz Laboratories annual reports for revenue, profit, balance sheet and cash flow data.
COLINZ Valuation Methods Summary — DCF, Graham Number & P/E
Colinz Laboratories intrinsic value across 8 models vs current price ₹42.01 — upside/downside and value range per method. For current market price and key ratios, visit Colinz Laboratories share price today.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹44.88 | ₹35.90 - ₹53.86 | +6.8% | EPS: ₹2.04, Sector P/E: 22x |
| Book Value Method | asset | ₹66.67 | ₹60.00 - ₹73.34 | +58.7% | Book Value/Share: ₹33.33, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹40.00 | ₹36.00 - ₹44.00 | -4.8% | Revenue/Share: ₹20.00, P/S: 2.0x |
| Simple DCF (5Y) | dcf | ₹30.95 | ₹24.76 - ₹37.14 | -26.3% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹32.64 | ₹29.38 - ₹35.90 | -22.3% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹30.02 | ₹27.02 - ₹33.02 | -28.5% | Revenue Growth: -3.8%, Adj P/E: 14.7x |
| ROE Based Valuation | profitability | ₹33.33 | ₹30.00 - ₹36.66 | -20.7% | ROE: 10.0%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹39.12 | ₹35.21 - ₹43.03 | -6.9% | EPS: ₹2.04, BVPS: ₹33.33 |
COLINZ Intrinsic Value vs Market Price — All Valuation Models
Colinz Laboratories fair value range ₹30–₹67 vs current market price ₹42.01 across 8 valuation models. Also explore COLINZ price trends to track price trends across different timeframes.
COLINZ Intrinsic Value Analysis — Undervalued or Overvalued?
Colinz Laboratories median intrinsic value ₹39.12, current price ₹42.01 — Trading Near Calculated Value by 6.9%, margin of safety -7.4%.
What is the intrinsic value of COLINZ?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Colinz Laboratories (COLINZ) is ₹39.12 (median value). With the current market price of ₹42.01, this represents a -6.9% variance from our estimated fair value.
The valuation range spans from ₹30.02 to ₹66.67, indicating ₹30.02 - ₹66.67.
Is COLINZ undervalued or overvalued?
Based on our multi-method analysis, Colinz Laboratories (COLINZ) appears to be trading near calculated value by approximately 6.9%.
COLINZ Financial Health — Key Ratios vs Industry Benchmarks
Colinz Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 10.0% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 7.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.46x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
COLINZ Cash Flow Quality — Operating & Free Cash Flow
Colinz Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-2 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |